Peritoneal surface malignancies comprise a heterogeneous group of primary tumours,
including peritoneal mesothelioma, and peritoneal metastases of other tumours, including …

Peritoneal surface malignancies (PSMs) are usually associated with a poor prognosis.
Nonetheless, in line with advances in the management of most abdominopelvic metastatic …

Cancer dissemination to peritoneal surfaces was, in the past, a lethal condition with a limited
survival. Clinical and pharmacologic research have shown that options for both treatment …

The Fourth International Workshop on Peritoneal Surface Malignancy took place in Madrid
(Spain) on December 2, 3 and 4, 2004. The meeting brought together 132 health care …

Peritoneal carcinomatosis, peritoneal sarcomatosis, and peritoneal mesothelioma are well-
known clinical entities. Carcinomatosis from colorectal, gastric, appendiceal, and ovarian …

Background: Peritoneal surface malignancy can result from seeding of gastrointestinal
cancer or abdominopelvic sarcoma; it can also occur as a primary disease, for example …

Peritoneal carcinomatosis (PC) is a common evolution of cancer of the gastrointestinal tract,
and has been traditionally regarded as a terminal disease with short median survival. During …

Peritoneal metastasis (PM) is often regarded as a less frequent pattern of spread; however,
collectively across all spectra of primary tumors, the consequences of PM impact a large …

Cancers originating from organs in the peritoneal cavity (eg, ovarian, pancreatic, colorectal,
gastric and liver) account for approximately 250,000 new cancer cases annually in the USA …

Diffuse malignant peritoneal mesothelioma (DMPM) has been traditionally regarded as a
rapidly lethal disease. Recently, several independent prospective trials have reported …